The economics of hemodialysis catheter-related infection prophylaxis

Seminars in Dialysis

Volumn 26, Issue 4, 2013, Pages 482-493

  Daisy Kosa, S ^a   Lok, Charmaine E ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CHRONIC KIDNEY FAILURE; DEVICE REMOVAL; ECONOMICS; FEMALE; HEALTH CARE COST; HUMAN; MALE; METHODOLOGY; PRIMARY PREVENTION; RENAL REPLACEMENT THERAPY; UNITED STATES;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CATHETER-RELATED INFECTIONS; CENTRAL VENOUS CATHETERS; DEVICE REMOVAL; FEMALE; HEALTH CARE COSTS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; PRIMARY PREVENTION; RENAL DIALYSIS; UNITED STATES;

EID: 84880689312     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/sdi.12115     Document Type: Article

References (103)

1. Operations and Business Management: Dialysis Market. http://reports.fmc-ag.com/reports/fmc/annual/2011/gb/English/20301040/dialysis-market.html - Dialysis_services, Fresinius Medical Care, 2009
2. USRDS: U.S. Renal Data System: USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, 2012
3. Ishani A, Collins A, Herzog C, Foley R: Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 study. Kidney Int 68:311-318, 2005
4. Engemann JJ, Friedman JY, Reed SD, Griffiths RI, Szczech LA, Kaye KS, Stryjewski ME, Reller LB, Schulman KA, Corey GR, Fowler VG: Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infect Control Hosp Epidemiol 26:534-539, 2005
5. Marr KA, Kong L, Fowler VG, Gopal A, Sexton DJ, Conlon PJ, Corey GR: Incidence and outcome of Staphylococcus aureus bacteremia in hemodialysis patients. Kidney Int 54:1684-1689, 1998
6. Maraj S, Jacobs LE, Kung SC, Raja R, Krishnasamy P, Maraj R, Braitman LE, Kotler MN: Epidemiology and outcome of infective endocarditis in hemodialysis patients. Am J Med Sci 324:254-260, 2002
7. USRDS: U.S. Renal Data System: USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, 2009
8. Ramanathan V, Chiu EJ, Thomas JT, Khan A, Dolson GM, Darouiche RO: Healthcare costs associated with hemodialysis catheter-related infections: a single-center experience. Infect Control Hosp Epidemiol 28:606-609, 2007
9. Mokrzycki MH, Zhang M, Cohen H, Golestaneh L, Laut JM, Rosenberg SO: Tunnelled haemodialysis catheter bacteraemia: risk factors for bacteraemia recurrence, infectious complications and mortality. Nephrol Dial Transplant 21:1024-1031, 2006
10. Tanriover B, Carlton D, Saddekni S, Hamrick K, Oser R, Westfall AO, Allon M: Bacteremia associated with tunneled dialysis catheters: comparison of two treatment strategies. Kidney Int 57:2151-2155, 2000
11. Lee H, Manns B, Taub K, Ghali WA, Dean S, Johnson D, Donaldson C: Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis 40:611-622, 2002
12. Reed SD, Friedman JY, Engemann JJ, Griffiths RI, Anstrom KJ, Kaye KS, Stryjewski ME, Szczech LA, Reller LB, Corey GR, Schulman KA, Fowler VG Jr: Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 26:175-183, 2005
13. Nissenson AR, Dylan ML, Griffiths RI, Yu HT, Dean BB, Danese MD, Dubois RW: Clinical and economic outcomes of Staphylococcus aureus septicemia in ESRD patients receiving hemodialysis. Am J Kidney Dis 46:301-308, 2005
14. First F: Fistula First National Vascular Access Improvements Initiative. http://www.fistulafirst.org/ 2010
15. (NIDDK) NIoHNaTNIoDaDaKD: Identification of Factors Associated with Failure of Arteriovenous Fistulas to Mature in Hemodialysis Patients (U01) 2007
16. Chan MR, Sanchez RJ, Young HN, Yevzlin AS: Vascular access outcomes in the elderly hemodialysis population: a USRDS study. Semin Dial 20:606-610, 2007
17. USRDS: U.S. Renal Data System: USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health. Costs of end-stage renal disease. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, 2010
18. CORR: 2010 CORR Report-treatment of end-stage organ failure in Canada, 1999 to 2008, 2010
19. Kosa S, Joarder Z, Gafni A, Lok C: Cost Analysis of the Hemodialysis Infection Prevention with Polyspring Ointment (HIPPO) Study. American Society of Nephrology Conference. San Diego, California: Journal of the American Society of Nephrology, 2012
20. Torrance GW, Stoddart GL, Drummond MF, Gafni A: Cost-benefit analysis versus cost-effectiveness analysis for the evaluation of long-term care programs. Health Serv Res 16:474-476, 1981
21. Allon M: Dialysis catheter-related bacteremia: treatment and prophylaxis. Am J Kidney Dis 44:779-791, 2004
22. Beathard GA, Urbanes A: Infection associated with tunneled hemodialysis catheters. Semin Dial 21:528-538, 2008
23. Cheesbrough JS, Finch RG, Burden RP: A prospective study of the mechanisms of infection associated with hemodialysis catheters. J Infect Dis 154:579-589, 1986
24. McCann M, Moore ZE: Interventions for preventing infectious complications in haemodialysis patients with central venous catheters. Cochrane Database Syst Rev 20:CD006894, 2010
25. Batistella M, Bhola C, Kosa S: Personal Communication. Toronto General Hospital: University Health Network, 2012
26. Treston-Aurand J, Olmsted RN, Allen-Bridson K, Craig CP: Impact of dressing materials on central venous catheter infection rates. J Intraven Nurs 20:201-206, 1997
27. Webster J, Gillies D, O'Riordan E, Sherriff KL, Rickard CM: Gauze and tape and transparent polyurethane dressings for central venous catheters. Cochrane Database Syst Rev 4: CD009261, 2011
28. Schwebel C, Lucet JC, Vesin A, Arrault X, Calvino-Gunther S, Bouadma L, Timsit JF: Economic evaluation of chlorhexidine-impregnated sponges for preventing catheter-related infections in critically ill adults in the Dressing Study. Crit Care Med 40:11-17, 2012
29. Timsit JF, Mimoz O, Mourvillier B, Souweine B, Garrouste-Orgeas M, Alfandari S, Plantefeve G, Bronchard R, Troche G, Gauzit R, Antona M, Canet E, Bohe J, Lepape A, Vesin A, Arrault X, Schwebel C, Adrie C, Zahar JR, Ruckly S, Tournegros C, Lucet JC: Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults. Am J Respir Crit Care Med, 12:1272-1278, 2012
30. Camins BC, Richmond AM, Dyer KL, Zimmerman HN, Coyne DW, Rothstein M, Fraser VJ: A crossover intervention trial evaluating the efficacy of a chlorhexidine-impregnated sponge in reducing catheter-related bloodstream infections among patients undergoing hemodialysis. Infect Control Hosp Epidemiol 31:1118-1123, 2010
31. Kosa S, Lok C: A Survey of Hemodialysis Practice Patterns in Canada for Hemodialysis Central Venous Catheters. Orlando, Florida: National Kidney Foundation, 2013
32. Directory of Participating Dialysis Centres, Transplant Centres, and Organ Procurement Organizations in Canada: Canadian Organ Replacement Register. North York, Ontario, Canada: Canadian Institute of Health Information, 2012
33. Jindal K, Chan CT, Deziel C, Hirsch D, Soroka SD, Tonelli M, Culleton BF: Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology. J Am Soc Nephrol 17:S1-27, 2006
34. Besarab A, Work J, Brouwer D, Klaus Konner K, Bunchman TE, Lumsden A, Dinwiddie LC, Vesely TM, Goldstein SL, Henry ML, Balk E, Uhlig K, Fares G, Mahajan A, Earley A, Persson R, Raman G, Yuhan CK, Chew P, Ip S, Chung M, Lau J, Levey AS: National Kidney Foundation Clinical Practice Guidelines for vascular access: Guideline 7. Prevention and treatment of catheter port complications. Am J Kidney Dis 48:S176-S247, 2006
35. Timsit JF, Bouadma L, Ruckly S, Schwebel C, Garrouste-Orgeas M, Bronchard R, Calvino-Gunther S, Laupland K, Adrie C, Thuong M, Herault MC, Pease S, Arrault X, Lucet JC: Dressing disruption is a major risk factor for catheter-related infections. Crit Care Med 40:1707-1714, 2012
36. Brandt B, DePalma J, Irwin M, Shogan J, Lucke JF: Comparison of central venous catheter dressings in bone marrow transplant recipients. Oncol Nurs Forum 23:829-836, 1996
37. Shivnan JC, McGuire D, Freedman S, Sharkazy E, Bosserman G, Larson E, Grouleff P: A comparison of transparent adherent and dry sterile gauze dressings for long-term central catheters in patients undergoing bone marrow transplant. Oncol Nurs Forum 18:1349-1356, 1991
38. O'Grady NP, Alexander M, Burns LA, Dellinger P, Garland J, Heard SO, Lipsett PA, Masur H, Mermel LA, Pearson ML, Raad II, Randolph A, Rupp ME, Saint S, (HICPAC) HICPAC: Guidelines for the Prevention of Intravascular Catheter-Related Infections. Bethesda, MD, USA: Centre for Disease Control and Prevention, 2011
39. Vanholder R, Canaud B, Fluck R, Jadoul M, Labriola L, Marti-Monros A, Tordoir J, Van Biesen W: Diagnosis, prevention and treatment of haemodialysis catheter-related bloodstream infections (CRBSI): a position statement of European Renal Best Practice (ERBP). NDT Plus 25:1753-1756, 2010
40. Manian FA: IDSA guidelines for the diagnosis and management of intravascular catheter-related bloodstream infection. Clin Infect Dis 49:1770-1771; author reply 1771-1772, 2009
41. Jindal K, Chan CT, Deziel C, Hirsch D, Soroka SD, Tonelli M, Culleton BF: Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology. Chapter 4: vascular access. J Am Soc Nephrol 17(Suppl 1):S16-23, 2006
42. Barrett B: Kidney Foundation Patient Fact Sheet. Montreal, Quebec, Canada: Kidney Foundation of Canada, 2011
43. Kosa S, Al Jaishi A, Joarder B, Tam P, Moist L, Lok C: Hemodialysis Patient Views on their Catheter Care Protocols. Canadian Society of Nephrology Annual General Meeting. St John's, Newfoundland: Canadian Society of Nephrology, 2012
44. Lawrence-Murphy JA, Seiler S, Hooton A, Pember A, and St. Roch C: Shower and no-dressing technique for tunneled central venous catheters: an update one year later. CANNT J 20:18, 2010
45. Altman S: Showering with central venous catheters: experience using the CD-1000 composite dressing. Dial Transplant 35:320-327, 2006
46. Wu G: Trends in hemodialysis catheter bacteremia rates at Credit Valley Hospital. Bloodstream Infections in Hemodialysis Patients: Local Symposium. Mississauga: Credit Valley Hospital, 2011
47. Kosa S: Hemodialysis Infection Prevention with Polysporin Ointment (PTO) Versus Taking a Wet Shower (HIPPO-TWO) Pilot Study Design. National Kidney Foundation Kidney Week 2012. American Journal of Kidney Diseases, 2012
48. Tordoir J, Canaud B, Haage P, Konner K, Basci A, Fouque D, Kooman J, Martin-Malo A, Pedrini L, Pizzarelli F, Tattersall J, Vennegoor M, Wanner C, ter Wee P, Vanholder R: EBPG on vascular access. Nephrol Dial Transplant 22(Suppl 2):ii88-117, 2007
49. Updated CDC Guidelines on Prevention of Catheter-Related Infections. http://www.accessdata.fda.gov/psn/printer-full.cfm?id=10, Food and Drug Administration, 2009, pp References the Centers for Disease Control and Prevention. Guidelines for the Prevention of Intravascular Catheter-Related Infections. MMWR 2002; 2051 (No. RR-2010). August 2009, 2002
50. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S: Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med 136:792-801, 2002
51. Maenthaisong R, Chaiyakunapruk N, Thamlikitkul V: Cost-effectiveness analysis of chlorhexidine gluconate compared with povidone-iodine solution for catheter-site care in Siriraj Hospital. Thailand. J Med Assoc Thai 89(Suppl 5):S94-101, 2006
52. Lok C, Thumma J, McCullough K, Gillespie B, Fluck R, Marshall M, Kawanishi H, Robinson B, Pisoni R: Catheter-related infection and septicemia: impact of seasonality and modifiable practices from the DOPPS. Semin Dial 2013, In Press
53. Frankel A: Temporary access and central venous catheters. Eur J Vasc Endovasc Surg 31:417-422, 2006
54. Foley RN, Chen SC, Collins AJ: Hemodialysis access at initiation in the United States, 2005 to 2007: still "catheter first". Hemodial Int 13:533-542, 2009
55. Ponikvar R: Hemodialysis catheters. Ther Apher Dial 9:218-222, 2005
56. Oliver MJ, Rothwell DM, Fung K, Hux JE, Lok CE: Late creation of vascular access for hemodialysis and increased risk of sepsis. J Am Soc Nephrol 15:1936-1942, 2004
57. Stevenson KB, Hannah EL, Lowder CA, Adcox MJ, Davidson RL, Mallea MC, Narasimhan N, Wagnild JP: Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data: predicting the impact of NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis 39:549-555, 2002
58. Weijmer MC, Vervloet MG, ter Wee PM: Compared to tunnelled cuffed haemodialysis catheters, temporary untunnelled catheters are associated with more complications already within 2 weeks of use. Nephrol Dial Transplant 19:670-677, 2004
59. Atapour A, Shahidi S, Sairafian S: Does tunneling the temporary vascular access extend its lifetime? J Res Med Sci 11:41-46, 2006
60. Bleyer AJ: Use of antimicrobial catheter lock solutions to prevent catheter-related bacteremia. Clin J Am Soc Nephrol 2:1073-1078, 2007
61. Manierski C, Besarab A: Antimicrobial locks: putting the lock on catheter infections. Adv Chronic Kidney Dis 13:245-258, 2006
62. Raad I, Bodey GP Sr: Novel antimicrobial catheter lock solution: a new direction in which chelators replace heparin. Crit Care Med 39:875-876, 2011
63. Sauer K, Steczko J, Ash SR: Effect of a solution containing citrate/Methylene Blue/parabens on Staphylococcus aureus bacteria and biofilm, and comparison with various heparin solutions. J Antimicrob Chemother 63:937-945, 2009
64. Takla TA, Zelenitsky SA, Vercaigne LM: Effectiveness of a 30% ethanol/4% trisodium citrate locking solution in preventing biofilm formation by organisms causing haemodialysis catheter-related infections. J Antimicrob Chemother 62:1024-1026, 2008
65. Qu Y, Istivan TS, Daley AJ, Rouch DA, Deighton MA: Comparison of various antimicrobial agents as catheter lock solutions: preference for ethanol in eradication of coagulase-negative staphylococcal biofilms. J Med Microbiol 58:442-450, 2009
66. Snaterse M, Ruger W, Scholte Op Reimer WJ, Lucas C: Antibiotic-based catheter lock solutions for prevention of catheter-related bloodstream infection: a systematic review of randomised controlled trials. J Hosp Infect 75:1-11, 2010
67. Yahav D, Rozen-Zvi B, Gafter-Gvili A, Leibovici L, Gafter U, Paul M: Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis 47:83-93, 2008
68. Jaffer Y, Selby NM, Taal MW, Fluck RJ, McIntyre CW: A meta-analysis of hemodialysis catheter locking solutions in the prevention of catheter-related infection. Am J Kidney Dis 51:233-241, 2008
69. James MT, Conley J, Tonelli M, Manns BJ, MacRae J, Hemmelgarn BR: Meta-analysis: antibiotics for prophylaxis against hemodialysis catheter-related infections. Ann Intern Med 148:596-605, 2008
70. Pervez A, Ahmed M, Ram S, Torres C, Work J, Zaman F, Abreo K: Antibiotic lock technique for prevention of cuffed tunnel catheter associated bacteremia. J Vasc Access 3:108-113, 2002
71. Landry DL, Sweet SJ, Gobeille SL, Haessler SD, Vaidya CK, Braden GL: Long-term gentamicin lock catheter prophylaxis is associated with gentamicin-resistant gram-positive bacteremias in chronic hemodialysis (abstract). American Society of Nephrology. San Diego: American Society of NephrologyAbstracts2View, pp. F-FC301, 2009
72. Dixon JJ, Steele M, Makanjuola AD: Anti-microbial locks increase the prevalence of Staphylococcus aureus and antibiotic-resistant Enterobacter: observational retrospective cohort study. Nephrol Dial Transplant 27:3575-3581, 2012
73. Polaschegg HD: Catheter locking-solution spillage: theory and experimental verification. Blood Purif 26:255-260, 2008
74. Moran J, Sun S, Khababa I, Pedan A, Doss S, Schiller B: A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients. Am J Kidney Dis 59:102-107, 2012
75. Hemmelgarn BR, Moist LM, Lok CE, Tonelli M, Manns BJ, Holden RM, LeBlanc M, Faris P, Barre P, Zhang J, Scott-Douglas N: Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator. N Engl J Med 364:303-312, 2011
76. Manns B, Scott-Douglas N, Klarenbach S, Moist L, Tonelli M, Ravani P, Au F, Dorval M, Lok C, Chui B, Wiebe N, Hemmelgarn B: A comparison of costs of using once weekly rt-PA or heparin as a locking solution for hemodialysis catheters: findings from the prevention of catheter lumen Occlusion with rt-PA versus heparin (Pre-CLOT) randomized trial. American Society of Nephrology. San Diego, California 2012, In press
77. Weijmer MC, van den Dorpel MA, Van de Ven PJ, ter Wee PM, van Geelen JA, Groeneveld JO, van Jaarsveld BC, Koopmans MG, le Poole CY, Schrander-Van der Meer AM, Siegert CE, Stas KJ; CITRATE Study Group: Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J Am Soc Nephrol 16:2769-2777, 2005
78. Power A, Duncan N, Singh SK, Brown W, Dalby E, Edwards C, Lynch K, Prout V, Cairns T, Griffith M, McLean A, Palmer A, Taube D: Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial. Am J Kidney Dis 53:1034-1041, 2009
79. Willicombe MK, Vernon K, Davenport A: Embolic complications from central venous hemodialysis catheters used with hypertonic citrate locking solution. Am J Kidney Dis 55:348-351, 2010
80. Lee T, Lok C, Vazquez M, Moist L, Maya I, Mokrzycki M: Minimizing hemodialysis catheter dysfunction: an ounce of prevention. Int J Nephrol 2012:170857, 2012
81. Lok CE, Appleton D, Bhola C, Khoo B, Richardson RM: Trisodium citrate 4%-an alternative to heparin capping of haemodialysis catheters. Nephrol Dial Transplant 22:477-483, 2006
82. Grudzinski L, Quinan P, Kwok S, Pierratos A: Sodium citrate 4% locking solution for central venous dialysis catheters-an effective, more cost-efficient alternative to heparin. Nephrol Dial Transplant, 22:471-476, 2006
83. Plamondon I, Agharazii EA, Langlois S, Desmeules S: Randomized cross-over comparison of 4% citrate and heparin for catheter lock of double lumen hemodialysis catheters (abstract). J Am Soc Nephrol 12A, 2005
84. Lok CE, Stanley KE, Hux JE, Richardson R, Tobe SW, Conly J: Hemodialysis infection prevention with polysporin ointment. J Am Soc Nephrol 14:169-179, 2003
85. Herwaldt LA: Reduction of Staphylococcus aureus nasal carriage and infection in dialysis patients. J Hosp Infect 40(Suppl B):S13-23, 1998
86. Sesso R, Barbosa D, Leme IL, Sader H, Canziani ME, Manfredi S, Draibe S, Pignatari AC: Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter: effect of mupirocin ointment. J Am Soc Nephrol 9:1085-1092, 1998
87. Johnson DW, MacGinley R, Kay TD, Hawley CM, Campbell SB, Isbel NM, Hollett P: A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters. Nephrol Dial Transplant 17:1802-1807, 2002
88. Johnson DW, van Eps C, Mudge DW, Wiggins KJ, Armstrong K, Hawley CM, Campbell SB, Isbel NM, Nimmo GR, Gibbs H: Randomized, controlled trial of topical exit-site application of honey (Medihoney) versus mupirocin for the prevention of catheter-associated infections in hemodialysis patients. J Am Soc Nephrol 16:1456-1462, 2005
89. Lok CE, Mokrzycki MH: Prevention and management of catheter-related infection in hemodialysis patients. Kidney Int 79:587-598, 2011
90. Annigeri R, Conly J, Vas S, Dedier H, Prakashan KP, Bargman JM, Jassal V, Oreopoulos D: Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection. Perit Dial Int 21:554-559, 2001
91. Perez-Fontan M, Rosales M, Rodriguez-Carmona A, Falcon TG, Valdes F: Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis. Am J Kidney Dis 39:337-341, 2002
92. Tacconelli E, Carmeli Y, Aizer A, Ferreira G, Foreman MG, D'Agata EM: Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. Clin Infect Dis 37:1629-1638, 2003
93. Lio PA, Kaye ET: Topical antibacterial agents. Infect Dis Clin North Am 23:945-963, ix 2009
94. Battistella M, Bhola C, Lok CE: Long-term follow-up of the Hemodialysis Infection Prevention with Polysporin Ointment (HIPPO) Study: a quality improvement report. Am J Kidney Dis 57:432-441, 2011
95. Hockenhull JC, Dwan K, Boland A, Smith G, Bagust A, Dundar Y, Gamble C, McLeod C, Walley T, Dickson R: The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation. Health Technol Assess 12:iii-iv, xi-xii, 1-154, 2008
96. Grimshaw J, Eccles M, Tetroe J: Implementing clinical guidelines: current evidence and future implications. J Contin Educ Health Prof 24(Suppl 1):S31-37, 2004
97. Levin A, Mason AJ, Jindal KK, Fong IW, Goldstein MB: Prevention of hemodialysis subclavian vein catheter infections by topical povidone-iodine. Kidney Int 40:934-938, 1991
98. Rabindranath KS, Bansal T, Adams J, Das R, Shail R, MacLeod AM, Moore C, Besarab A: Systematic review of antimicrobials for the prevention of haemodialysis catheter-related infections. Nephrol Dial Transplant 24:3763-3774, 2009
99. Solomon LR, Cheesbrough JS, Ebah L, Al-Sayed T, Heap M, Millband N, Waterhouse D, Mitra S, Curry A, Saxena R, Bhat R, Schultz MJ, Diggle P: A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis (in press). Am J Kidney Dis, 55(6):1060-1068, 2010
100. Campos RP, do Nascimento MM, Chula DC, Riella MC: Minocycline-EDTA lock solution prevents catheter-related bacteremia in hemodialysis. J Am Soc Nephrol 22:1939-1945, 2011
101. Maki DG, Ash SR, Winger RK, Lavin P, Investigators AT: A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: a multi-center, controlled, randomized trial. Crit Care Med 39:613-620, 2011
102. Le Corre I, Delorme M, Cournoyer S: A prospective, randomized trial comparing a transparent dressing and a dry gauze on the exit site of long term central venous catheters of hemodialysis patients. J Vasc Access 4:56-61, 2003
103. Labriola L, Crott R, Desmet C, Andre G, Jadoul M: Infectious complications following conversion to buttonhole cannulation of native arteriovenous fistulas: a quality improvement report. Am J Kidney Dis 57:442-448, 2011